Le Lézard
Classified in: Health
Subject: SVY

Global Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017


LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Gaucher's Disease patients study in a new report 'Global Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017'.

Download the full report: https://www.reportbuyer.com/product/3895282

The report provides insights into Gaucher's Disease epidemiology, Gaucher's Disease diagnosed patients, and Gaucher's Disease treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gaucher's Disease derived from epidemiological analysis, percentage of patients diagnosed with Gaucher's Disease, and percentage of patients treated with a therapy.

The study helps executives estimate Gaucher's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Gaucher's Disease prevalence, Gaucher's Disease diagnosis rate, and Gaucher's Disease treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Gaucher's Disease Patient Flow
- Gaucher's Disease Prevalence
- Gaucher's Disease Diagnosed Patients
- Gaucher's Disease Treated Patients

Download the full report: https://www.reportbuyer.com/product/3895282

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent to Attend Planet MicroCap Showcase
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
Honoring Audrey Beverly Christy Mastroianni at United Breast Cancer Foundation's Mattress and Pink Bag Event: "Gifts of Comfort and Hope" in Warwick, Rhode Island
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

at 17:31
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

at 17:31
Global Corneal Implant Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2030 | DelveInsight
DelveInsight's Corneal Implant Market...

at 17:26
Inception Fertilitytm & The Prelude Network® Tell Aspiring Parents 'We Get You, So We Got You' to Humanize the Fertility Experience
In observance of National Infertility Awareness Week (April 21-27, 2024), Inception Fertilitytm, a global leader of fertility services, and The Prelude Network®, Inception's clinical network and the largest network of fertility providers in North...

More news about Health...


News published on and distributed by: